Lumos Diagnostics has kicked off a key paediatric study in the US for its FebriDx rapid diagnostic test, marking a ...
GeneDx announces that the FDA has granted Breakthrough Device Designation for its whole genome and exome tests.
Can your bathroom double as a lab? At-home testing is reshaping how we learn about our bodies — and raising new questions.
Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2025, before the market opens on Tuesday, November 4, ...
Stockhead on MSN
Lumos Diagnostics partners with WellStreet Urgent Care to advance FebriDx testing in US
Special Report: Lumos Diagnostics has inked an agreement with WellStreet Urgent Care to expand the use of its FebriDx rapid ...
GlobalData on MSN
Thermo Fisher launches new test to assess lung transplant rejection
Thermo Fisher Scientific has launched the new Molecular Microscope Diagnostic System for Lung (MMDx Lung), a new test to ...
The ASX 200 slid 64 points today, retreating as traders took profits on yesterday’s all-time closing high and gold prices ...
Outfront Health launches virtually painless at-home biomarker kits with lab analysis & secure portal, helping adults track performance & longevity.
The cruise industry will extend its suspension of U.S. cruise operations through Dec. 31, an industry group that represents 95% of global ocean-going cruise capacity said on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback